2,3-Difluoro-6-methoxybenzaldehyde is an aromatic aldehyde in which the benzene ring bears fluorine substituents at the 2- and 3-positions and a methoxy substituent at the 6-position relative to the aldehyde. Its molecular formula is C8H6F2O2 (molecular weight 172.13 g mol−1) and its CAS registry number is 187543-87-9. The compound is used primarily as a fluorinated building block in medicinal chemistry and organic synthesis. Its fluorinated aromatic core provides enhanced metabolic stability, modulated electronic properties and increased lipophilicity compared with non-fluorinated analogues, making it a valuable reagent in drug discovery.
The development of 2,3-difluoro-6-methoxybenzaldehyde derives from the growing interest in fluorinated aromatic building blocks during the late 20th and early 21st centuries. Fluorine incorporation in drug molecules became widely adopted because of the unique properties of the C–F bond, such as high bond strength, small steric size and strong electron-withdrawing capability. This encouraged chemists to develop accessible fluorinated intermediates for library synthesis. One reported synthesis converts 3,4-difluoroanisole into the aldehyde by deprotonation with lithium diisopropylamide at -75 °C, followed by formylation with N,N-dimethylthioformamide (Vilsmeier-type protocol) to give the target aldehyde in ~95 % yield. This route demonstrates how organolithium chemistry can be applied to fluoro-substituted anisoles and subsequent work-up affords the crystalline aldehyde. The availability of this reagent commercially (≥97% purity) attests to its status as a reliable building block.
Applications of 2,3-difluoro-6-methoxybenzaldehyde are primarily as an intermediate in the synthesis of more complex molecules. In medicinal-chemistry programmes the aldehyde function serves as a site for condensation (e.g., formation of imines, Schiff bases), reduction to the corresponding alcohol, or oxidation to acids; the fluorinated aromatic core remains intact while further derivatisation introduces heterocycles, amines or other substituents. For example, the presence of the 2,3-difluoro pattern on the aromatic ring can improve metabolic resistance or binding affinity when the ring is incorporated into a pharmacophore. Its methoxy substituent at the 6-position further modifies electronic density and serves as a potentially removable or modifiable group. Because of these properties, the aldehyde is found in the synthetic sequences of fluorinated APIs, agrochemicals and advanced intermediates for library generation. Florescent building‐block studies and reviews on fluorinated intermediates cite this type of compound as part of the toolkit for early-stage drug discovery.
In practical laboratory use, the compound is stored under inert atmosphere (nitrogen or argon) at low temperature (2-8 °C) to minimise oxidation of the aldehyde group and degradation of the fluoro-substituted aromatic. The relatively low melting point (~55-57 °C) and the indication of air sensitivity from supplier data underscore the care needed in storage. Before use, the compound is characterised by NMR (¹H and ¹³C), which for the aldehyde proton appears typically at ~10.40 ppm, aromatic protons around 7.3–6.7 ppm, and a methoxy signal at ~3.93 ppm. The structure is further confirmed by mass spectrometry and elemental analysis. The fluorinated building-block nature of this aldehyde means that in downstream synthetic operations reaction conditions must be chosen to preserve the C–F bonds and avoid unwanted defluorination.
In summary, 2,3-difluoro-6-methoxybenzaldehyde is a well-established fluorinated aromatic aldehyde reagent, developed in response to the rise of organofluorine chemistry, and widely used as a structural module in drug-discovery synthesis. Its combination of fluorine substituents, methoxy group and reactive aldehyde makes it a versatile starting point for the introduction of fluorinated aromatic rings into complex small molecules and hybrid scaffolds.
References
Puterová Z, Krutošíková A & Végh D (2010) Gewald reaction: synthesis, properties and applications of substituted 2-aminothiophenes. ARKIVOC 2010 (i) 209–246. DOI: 10.3998/ark.5550190.0011.105
Grygorenko O O & Melnykov K P (2024) Fluorinated building blocks in drug design: new pathways and targets. Future Medicinal Chemistry 16(14) 1375–1378. DOI: 10.1080/17568919.2024.2379229
Malykhin E V, Acevedo J, Van der Ven H, McDonald R & Rappe A (1998) Preparation of 2,6-difluoro-n-alkylbenzenes from 1,3-difluorobenzene. Journal of Fluorine Chemistry 89 2 79–84. DOI: 10.1016/S0022-1139(98)00199-7
|
GHS07 Warning Details
Discovery and Applications